In the Cancer Genome Atlas (TGCA) AML cohort, four patients out of 200 were identified with mutations in the miRNA MIR142, all of which were exclusively identified in IDH-mutated AML samples, suggesting a strong genetic cooperation between these two types of mutation1. This evidence concerns the gene IDH2 and acute myeloid leukemia.